UOL COVID-19 Test
COVID-19
ApprovedActive
Key Facts
About Uh-Oh Labs
Uh-Oh Labs is a private, commercial-stage diagnostics company that has successfully launched its first product: the FDA-authorized UOL COVID-19 Test system. The company's proprietary Loop-de-Loop™ RT-LAMP platform forms the basis for a portable, rapid, and cost-effective molecular diagnostics system, which has garnered significant non-dilutive funding from the NIH's RADx initiative. With a core focus on infectious disease diagnostics, Uh-Oh Labs is leveraging its initial commercial foothold and strong financial backing to develop additional tests for its platform, targeting expansion beyond COVID-19.
View full company profileTherapeutic Areas
Other COVID-19 Drugs
| Drug | Company | Phase |
|---|---|---|
| COVID-19 Severity Prediction Test | Age Labs | Development |
| PanCytoVir™ (oral probenecid) | TrippBio | Phase 2 |
| ARCoV | Abogen | Approved (EUA) |
| OT-101 | Sapu BioScience | Clinical Trial (Phase not specified) |
| COVID-19 Vaccine (Inactivated) | Kangtai Biological Products | Approved |
| COVID-19 Vaccine (Adenovirus Vector) | Kangtai Biological Products | Approved |
| Idylla SARS-CoV-2 Test | Biocartis | Approved |
| Adjuvanted Cell-Based COVID-19 Vaccine | CSL Seqirus | Marketed |
| Sequential Dialysis Technique | Halberd | Discovery |
| Amubarvimab + Romlusevimab (BRII-196/BRII-198) | Brii Biosciences | Approved |
| COVID-19 Vaccine Testing (for AstraZeneca) | Advaxia Biologics | Approved |
| COVID-19 Vaccine Clinical Batches | Advaxia Biologics | Clinical |